Issue 07 · Getting Started
Why the Compound Is the Last Thing You Need to Worry About
"The biggest risk in peptide use isn't the peptide"
Peptides used for health optimization in the US are not FDA-regulated for human use. They're marketed as "research chemicals" — a legal category that makes their sale possible but removes virtually all quality control requirements.
There is no mandatory purity testing for research peptides. No sterility standards. No labeling verification. No cold chain enforcement during shipping.
That doesn't mean all research peptide vendors are selling garbage. It means there is nothing stopping them from doing so. The quality difference between a good vendor and a bad one is entirely voluntary — it reflects their investment in synthesis quality, testing infrastructure, and reputation. Some invest heavily. Some don't.
Anti-doping laboratories analyzing performance-enhancing supplements have documented substituted peptides, incorrect concentrations, and contamination products in the research peptide market. This is documented, not theoretical.
Wrong concentration. A vial labeled 5mg contains 2mg or 8mg. Under-dosed: you see no effect and conclude the peptide doesn't work, when the issue is just the concentration. Over-dosed: you experience amplified side effects at what you thought was a conservative starting dose.
Wrong peptide sequence. Truncated or incorrect sequences — the result of incomplete synthesis reactions — may have partial agonist or antagonist activity at your target receptor. They might blunt the effect of the correct peptide you're also receiving. You'll never know.
Identity substitution. The vial contains a different peptide than labeled. Cheaper compounds substituted for more expensive ones. Without mass spectrometry, you can't tell.
Endotoxin contamination. This is the one with real medical consequences. Bacterial endotoxins in injectable solution trigger immune response — fever, chills, systemic inflammatory symptoms. In severe cases: hospitalization. This is what happens when you inject bacterial debris rather than pure peptide. Synthesis under non-sterile conditions introduces these contaminants; you can't see them and can't smell them.
If you inject something and develop fever and chills within hours: that's the warning sign. Stop immediately and get evaluated.
A reputable vendor publishes analytical data. Not marketing language — actual documents from laboratories.
Third-party Certificate of Analysis (CoA). The most important document. A CoA from an independent analytical laboratory confirms the identity and purity of what's in the vial. The key word is third-party: a CoA from the vendor's own internal lab is not independent verification. You want a CoA that names an external laboratory, ideally with contact information you could use to verify.
HPLC purity ≥98%. High-performance liquid chromatography measures peptide purity. Greater than 98% is the standard for quality synthesis. Anything significantly below that means you're getting meaningful amounts of something that isn't the stated peptide.
Mass spectrometry identity confirmation. HPLC tells you purity; mass spec tells you identity — that the peptide is the correct sequence at the correct molecular weight. Both matter.
Endotoxin testing (LAL test). Limulus Amebocyte Lysate testing measures bacterial endotoxin levels. A vendor that publishes LAL results is taking sterility seriously. Absence of endotoxin data is a yellow flag.
Batch traceability. The vial has a batch number; the CoA on the website is tied to that batch number. Generic CoAs not linked to specific batches tell you little.
Lyophilized (freeze-dried) product. High-quality vendors ship powder. You reconstitute it yourself under controlled conditions. Pre-dissolved injectables have compromised stability and greater contamination risk.
No third-party CoA. If you can't find an independent CoA on the vendor's website, that's a problem.
"99% pure — guaranteed" without documentation. Anyone can print that on a label. The question is whether they can show you the analytical data.
Unusually low prices. Peptide synthesis is not cheap. The reagents, the synthesis equipment, the analytical testing — these all cost money. A vendor offering BPC-157 at 30% of what competitors charge is almost certainly cutting corners somewhere in that chain.
No identifiable business address. Reputable vendors are real businesses with physical addresses. Anonymous storefronts have no accountability.
Pre-dissolved solution. A convenience that comes at the cost of stability and sterility certainty.
For peptides available through compounding pharmacies with a prescription, this is the cleaner pathway.
USP 797 standards govern sterility for compounding pharmacies. These are actual enforced standards — not pharmaceutical manufacturing standards, but significantly more rigorous than the research peptide market. A compounding pharmacy can be inspected; a research peptide website cannot.
Currently available with prescription from compounding pharmacies (availability varies by state and is shifting as FDA scrutiny increases): BPC-157, TB-500 (access tightening), ipamorelin, CJC-1295, gonadorelin, PT-141, GHK-Cu in various formulations.
Cost is 2–5x research peptide pricing. That's real money. But if you're using these compounds long-term, the sterility assurance and physician oversight have value.
If you have a functional medicine or men's health physician as part of your protocol, use the compounding pathway for what's available.
High-quality lyophilized peptide can still be compromised by poor reconstitution. Two rules:
Use bacteriostatic water (BW), not sterile water. Bacteriostatic water contains benzyl alcohol that prevents bacterial growth. A vial of sterile water opened and used repeatedly can support bacterial growth within days. BW stays clean for the shelf life of the reconstituted peptide. Use BW. It's available at pharmacies and online medical supply vendors without prescription.
Don't shake — swirl. Add the bacteriostatic water gently down the inside wall of the vial (not directly onto the powder). Swirl gently to dissolve. Vigorous shaking can mechanically degrade peptide structure. The reconstituted solution should be clear and colorless with no visible particles. If it's cloudy, discolored, or has particulate matter, don't use it.
In priority order:
The sourcing and safety work happens once — before you start a protocol. Get it right at the beginning and you don't have to think about it again until you add something new. Get it wrong and the biology becomes irrelevant; you're not working with the compound you think you're working with.
Next issue: The testosterone question — TRT, axis support, and how to think about the decision if you're sitting on borderline labs.